SYNTHESIS AND ANTICANCER ACTIVITY OF 5- CHLORO-3-((6-CHLORO- [1,2,4]TRIAZOLO[4,3- b]PYRIDAZIN-3-YL)METHYL)BENZO[d]THIAZOL- 2(3H)- ONE

Creative Commons License

Akdağ M., Arslan G., Oruç H., Özçelik A. B.

International Multidisciplinary Symposium on Drug Research and Development - DRD 2023, İzmir, Türkiye, 6 - 08 Mayıs 2023, ss.174, (Tam Metin Bildiri)

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Basıldığı Şehir: İzmir
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.174
  • Süleyman Demirel Üniversitesi Adresli: Evet

Özet

Breast cancer is the most common cause of cancer cases among women worldwide estimated to cause 1 million deaths in 2040 [1]. Heterocycles are important building blocks of anticancer agents [2]. Of the aromatic heterocycle compounds, it has been widely reported that nitrogenbased heterocycles and benzothiazole derivatives have anticancer properties [2-4]. In this study, benzothiazol-2(3H)-one and [1,2,4]triazolo[4,3-b]pyridazine cores were merged and 5- chloro-3-((6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)benzo[d]thiazol-2(3H)-one compound was designed. The compound was synthesized by both conventional and microwave irradiation methods. It was evaluated against MCF-7 breast cancer cells